Our vision is to improve human well-being by empowering researchers to better understand complex diseases and develop personalized therapies. We develop and market PET nuclear imaging products to allow medical professionals at leading hospitals, universities and pharmaceutical companies to non-invasively visualize and measure biochemical processes at the molecular level.

Applications for our products include preclinical drug development and disease research in oncology, neurological, and cardiovascular areas. Our multimodal preclinical in vivo imaging systems feature ultra-compact scanner footprints and excellent resolution, sensitivity and image quality.

Cubresa Inc.

Org chart

Teams

Offices